Interatrial Shunt Devices Market Size, Share & Trends Analysis Report By Product | Forecast to 2029
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Will The Interatrial Shunt Devices Market Valuation Change Between Now And 2029?
The market for interatrial shunt devices has experienced significant expansion in the recent past. The market value, which will be $2.63 billion in 2024, is projected to rise to $2.90 billion in 2025, indicating a compound annual growth rate (CAGR) of 10.5%. The substantial growth during the historic era can be linked to increased clinical proof endorsing their effectiveness and safety, heightened demand for efficient pulmonary hypertension management, an escalating occurrence of comorbidities, an increased number of regulatory approvals for trial shunt systems, and a growing predilection for outpatient cardiac care and ambulatory services.
The market size for interatrial shunt devices is predicted to experience quick expansion in the coming years. It’s anticipated to rise to $4.28 billion by 2029, with a compound annual growth rate (CAGR) of 10.2%. The evolution in the projection period is due to enhanced incidence of heart failure, increasing numbers of elderly, heightened awareness surrounding minimal invasive cardiac procedures, upsurge in health care expense, and greater acceptance of catheter-based methods. Key trends within the forecast period are technological disruptions in shunt device materials, the miniaturization of interventional devices driven by technology, incorporation of live imaging and navigation systems, improvements in catheter-based delivery systems, and progress in hemodynamic monitoring technologies.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25798&type=smp
What Underlying Factors Are Supporting The Interatrial Shunt Devices Market Growth?
The increasing incidences of heart failure are anticipated to drive the expansion of the interatrial shunt devices market. Heart failure is a condition where the heart cannot pump blood effectively, resulting in insufficient oxygen and nutrients delivery to tissues. The heightened number of hypertension cases, which gradually weakens the heart’s pumping ability, is contributing to the rise in heart failure. Interatrial shunt devices alleviate heart failure by creating a small opening between the left and right atria. This allows excess pressure from the overloaded left side of the heart to be transferred to the right side, reducing pulmonary congestion and enhancing symptoms. For example, the Heart Failure Society of America, a US-based professional group, reported in September 2024 that about 6.7 million Americans aged 20 and above are living with heart failure. This figure is projected to reach 11.4 million by 2050. Consequently, the escalating rate of heart failure is fueling the growth of the interatrial shunt devices market.
Which Sub-Segments Are Driving Growth Within The Interatrial Shunt Devices Market?
The interatrial shunt devices market covered in this report is segmented –
1) By Device Type: Implantable Shunt Devices, Temporary Shunt Devices
2) By Delivery Method: Surgical Delivery, Transcatheter Delivery
3) By Material: Nitinol, Polyester, Polyproplene
4) By Application: Congenital Heart Disease, Heart Failure, Stroke Prevention
5) By End-User: Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories, Other Users
Subsegments:
1) By Implantable Shunt Devices: Single-Lumen Shunt Devices, Expandable Shunt Devices, Multi-Lumen Shunt Devices
2) By Temporary Shunt Devices: Balloon-Assisted Shunt Devices, Percutaneous Temporary Shunt Devices, Catheter-Based Shunt Devices
What Future-Focused Trends Are Anticipated In The Interatrial Shunt Devices Market?
Leading enterprises within the interatrial shunt devices market are concentrating on creating unique solutions, such as initiating the first-in-human (FIH) clinical trial. This trial is aimed at assessing the safety and effectiveness of new shunt technologies designed to lower left atrial pressure in individuals suffering from heart failure. The term first-in-human (FIH) clinical trial is related to the initial phase of testing a fresh medical device or medication in humans, with the objective of determining its safety, tolerability, and preliminary effectiveness following successful preclinical studies. Case in point, Adona Medical Inc., a medical tech firm based in the US, successfully enrolled participants for its first-in-human (FIH) clinical trial, known as ATHENS-HF, for an innovative interatrial shunt meant to assist heart failure patients in January 2025. This device is among the initial ones to integrate therapeutic shunting with intrinsic bi-atrial pressure monitoring, aiming to provide a more tailored and adaptive heart failure management approach.
Which Companies Hold A Competitive Edge In The 111 Market?
Major companies operating in the interatrial shunt devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc., Terumo Corporation, Edwards Lifesciences Corporation, Cook Medical, Integra LifeSciences Holdings Corporation, Lepu Medical Technology (Beijing) Co. Ltd., B. Braun Melsungen AG., W. L. Gore & Associates Inc., Venus Medtech Inc., Occlutech Holding AG., Wuhan Vickor Medical Technology Co. Ltd., Corvia Medical Inc., Xeltis BV, Alleviant Medical Inc., Cerevasc Inc., Adona Medical Inc., Carag AG., InterShunt Technologies Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/interatrial-shunt-devices-global-market-report
Which Region Dominates The Interatrial Shunt Devices Market Today?
North America was the largest region in the interatrial shunt devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the interatrial shunt devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25798&type=smp
Browse Through More Reports Similar to the Global Interatrial Shunt Devices Market 2025, By The Business Research Company
Ventricular Assist Device Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report
Left Ventricular Assist Devices Global Market Report 2025
Congestive Heart Failure Treatment Devices Global Market Report 2025
About The Business Research Company:
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
